Ablexis
PrivateLast Round
M&A
Jun 21, 2018
Total Funding Raised
$12M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ablexis is a biotechnology company that provides the AlivaMab Mouse, a transgenic mouse platform for the discovery of therapeutic antibodies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ablexis Comparables
Compare Ablexis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbTherx, Inc. | 87% | |
| OmniAb Inc. | 85% | |
| Harbour BioMed | 82% | |
Ablexis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jun 21, 2018 | ||||
| Series A | Jun 2, 2010 |
Ablexis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deerfield Management | M&A |
| Pfizer Ventures | Series A |
| Third Rock Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors grew 95% MoM.
- Nov 10, 2025
Monthly visitors increased 43% MoM.
Ablexis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ablexis's valuation, stock price, and market status.